Share Our Stories! - Click Here
Breast Cancer Now & Tamoifen
Dr. Betty Martini D.Hum
BCN - UK , funded by AstraZeneca, Lilly, Novartis, Roche, Fizer and Myriad Genetics of hereditary breast cancer fame.
One non-mushroom woman ( not happy being kept in the dark and fed manure ) - a professor of geochemistry, took charge of her own health and reversed her breast cancer through the elimination of dairy produce : standard holistic advice.
BCN - component , Breakthrough , called this " worrying ". Understandably, non-drug approaches to cancer and prevention are not part of BCN's ideas on the disease. Nutritional cures are definitely " worrying " : the main concern being that women might discover that the basic difference between the rural Chinese woman with a very low cancer rate and the UK/US woman , with a very high rate, is dairy produce and other animal foods in the diet .
The AstraZeneca drug Tamoxifen, with its multitude of dangerous effects,
death-included is the way forward : none of this natural nonsense .
Studies have suggested an increased risk of uterine cancer, 6.4 times
higher for those women taking tamoxifen. Gusberg SB Cancer 65 1990
Drug maker may quit cancer trial - Healthy women taking part in a clinical trial to prevent breast cancer might have been put at a risk of developing other tumours...the drug may increase the risk of tumours in the womb, liver and bowel. The disclosure, on the eve of the launch...has led to the manufacturer threatening to pull out. Times 12 Oct 1995
Hamish Cameron, head of medical affairs at Zeneca, the drug's makers, stated: Should the benefit/risk balance shift adversely, we reserve the right to withdraw that drug supply. If the evidence is quite clear I would hope the trialists themselves would realise that the game is up .
Dr.Richard Bulbrook, one of the original proposers of the tamoxifen enterprise, voiced his concerns: Things have changed. There are now so many side-effects reported - there were 41 at the last count - and some of these are fatal. : all in sharp contrast to Gordon McVie , then , ' scientific director ' of the 'Cancer Research Campaign': What we want to know is can we get more mileage out of tamoxifen, possibly by giving it for life. BCN controls The UK All Party Parliamentary Group on Breast Cancer.
The APPG is, currently, " investigating " ie rubber-stamping the BCN/AZ agenda on " breast cancer risk, early detection : access to gold standard treatments and to information and support .
Not only is the APGBC unable to see through BCN or any of the other pharma-dominated cancer groups, the APG has made BCN the APG " secretariat " : ".. responsible for the secretarial, clerical, and administrative affairs.." : no doubt, an impartial filter for those trying to contact the APG ... all highly amusing, except for the pain , mutilation, deaths of the ,annual, 12,000 UK women who take the lethal advice of the fraudsters who make up the cancer industry.